Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oteseconazole for Salvage Consolidation Therapy in Dimorphic Fungi
NCT07804368Phase 2Not yet recruiting
- Sponsor
- University of Minnesota
- Start
- Dec 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
A Phase 2 trial of oteseconazole in coccidioidomycosis, blastomycosis, histoplasmosis, sponsored by University of Minnesota. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
oteseconazole
03
Conditions
coccidioidomycosisblastomycosishistoplasmosis
Beyond the preview
Go deeper on NCT07804368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07804368.